首页> 美国卫生研究院文献>Current Therapeutic Research Clinical and Experimental >Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats
【2h】

Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats

机译:辅酶Q10预处理对异丙肾上腺素诱发的大鼠心脏毒性和心肌肥大的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Coenzyme Q10 (CoQ10) is a lipid-soluble, vitamin-like substance found in the hydrophobic interior of the phospholipid bilayer of most cellular membranes. It appears to be involved in the coordinated regulation between oxidative stress and antioxidant capacity of heart tissue when the heart is subjected to oxidative stress in various pathogenic conditions.>Objective: The objective of the present study was to investigate the effect of pretreatment with CoQ10 (100 mg/kg) on isoproterenol (ISO)-induced cardiotoxicity and cardiac hypertrophy in rats.>Methods: Albino male Wistar rats (250–300 g) were evenly divided by lottery method into 1 of the following 3 groups: the ISO group (olive oil 2 mL/kg orally for 18 days and ISO 1 mg/kg IP from days 9–18); the CoQ10 + ISO group (CoQ10 100 mg/kg orally for 18 days and ISO 1 mg/kg IP from days 9–18); and the control group (olive oil 2 mL/kg orally for 18 days and water IP from days 9–18). Twenty-four hours after the last dose of water or ISO, the rats were anesthetized and an ECG was recorded. Blood was withdrawn by retro-orbital puncture for estimation of serum creatine kinase-MB (CK-MB) isoenzyme levels, lactate dehydrogenase (LDH) levels, and aspartate aminotransferase activities. The animals were euthanized using an overdose of ether. The hearts of 6 animals from each group were used for estimation of superoxide dismutase (SOD) activity, reduced glutathione (GSH) concentration, lipid peroxidation (LPO), malondialdehyde (MDA), and total protein concentration. Histopathology of the 2 remaining hearts in each group was carried out by a blinded technician.>Results: A total of 24 rats (8 in each group) were used in this study; all rats survived to study end. Compared with the control group, the ISO-treated rats had a significant change in heart to body weight ratio (P < 0.001); significant changes in the endogenous antioxidants (ie, significantly higher myocardial MDA concentration [P < 0.001]; significantly lower myocardial GSH concentration [P < 0.001] and SOD activity [P < 0.01]); and significantly higher serum activities of marker enzymes (eg, CK-MB [P < 0.001] and LDH [P < 0.001]). Compared with the ISO group, the CoQ10 + ISO group had a significant change in heart to body weight ratio (P < 0.001); significant changes in the endogenous antioxidants (ie, significantly lower MDA concentration [P < 0.05]; significantly higher myocardial GSH concentration [P < 0.001] and SOD activity [P < 0.05]); and significantly lower serum activities of marker enzymes (eg, CK-MB [P < 0.05] and LDH [P < 0.01]).>Conclusion: Pretreatment with CoQ10 (100 mg/kg) for 18 days was associated with moderate protection against ISO-induced cardiotoxicity and cardiac hypertrophy, and with lower myocardial injury by preserving endogenous antioxidants and reducing LPO in rat heart.
机译:>背景:辅酶Q10(CoQ10)是一种脂溶性,类似维生素的物质,存在于大多数细胞膜的磷脂双层的疏水内部。当心脏在各种致病条件下遭受氧化应激时,似乎参与了心脏组织的氧化应激与抗氧化能力之间的协调调节。>目的:本研究的目的是研究心脏的氧化应激与抗氧化能力之间的协调关系。 CoQ10(100 mg / kg)预处理对异丙肾上腺素(ISO)诱导的大鼠心脏毒性和心脏肥大的影响。>方法:用抽签方法将白化雄性Wistar大鼠(250–300 g)均分分为以下3组中的1组:ISO组(橄榄油2 mL / kg口服,持续18天,ISO 1 mg / kg IP,从9-18天开始); CoQ10 + ISO组(CoQ10 100 mg / kg口服,持续18天,ISO 1 mg / kg IP,从第9-18天开始);对照组(口服橄榄油2 mL / kg,持续18天,腹腔注射IP,从9-18天开始)。最后一剂水或ISO注射后二十四小时,将大鼠麻醉并记录ECG。通过眼眶后穿刺抽取血液以评估血清肌酸激酶-MB(CK-MB)同工酶水平,乳酸脱氢酶(LDH)水平和天冬氨酸转氨酶活性。使用过量的乙醚使动物安乐死。每组的6只动物的心脏用于评估超氧化物歧化酶(SOD)活性,降低的谷胱甘肽(GSH)浓度,脂质过氧化(LPO),丙二醛(MDA)和总蛋白浓度。由盲人技术人员对每组剩下的2个心脏进行组织病理学检查。>结果:本研究共使用了24只大鼠(每组8只)。所有大鼠均存活至研究结束。与对照组相比,接受ISO治疗的大鼠的心体重比有显着变化(P <0.001)。内源性抗氧化剂的显着变化(即,心肌MDA浓度显着较高[P <0.001];心肌GSH浓度显着较低[P <0.001]和SOD活性[P <0.01]);并显着提高标记酶的血清活性(例如CK-MB [P <0.001]和LDH [P <0.001])。与ISO组相比,CoQ10 + ISO组的心体重比有显着变化(P <0.001);内源性抗氧化剂的显着变化(即,MDA浓度显着降低[P <0.05];心肌GSH浓度显着更高[P <0.001]和SOD活性[P <0.05]);并且显着降低了标记酶的血清活性(例如CK-MB [P <0.05]和LDH [P <0.01])。>结论: CoQ10(100 mg / kg)预处理18天通过保护内源性抗氧化剂和减少大鼠心脏中的LPO,可以适度保护免受ISO诱导的心脏毒性和心脏肥大,并降低心肌损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号